Clinical trial
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO…
NCT00258076 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00258076 |
|---|---|
| Title | A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch) |
| Official title | Open-Label, Randomized, Partially Balanced, Incomplete Block Design Sudy to Evaluate the Hormone Exposure From Commercial ORTHO EVRA |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Contraception, Female Contraception |
| Intervention type | Drug |
| Interventions | EVRA transdermal contraceptive patch 6 mg NGMN and 0.75 mg EE |
| Enrollment | 53 |
| Start date | Apr 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Nov 24, 2005 |
| Last update posted | Dec 12, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: